-
Study States Combo Therapies For Comorbidities May Affect IPF’s Progression
Senior Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses a study that states that combo therapies for comorbidities may affect IPF’s progression.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/
What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!
-
2 Replies
-
Who did this study and where can we find texts or articles presented on your podcasts?Thanks
Barry McGee
-
@fotoimagini
Hi Barry, I checked with the team who published this podcast and they sent me this link, saying the study can be found here. It seems inconclusive and unclear to me (more of a research letter than formal study) but take a peak and let me know if this is what you were looking for: https://pulmonaryfibrosisnews.com/2019/09/27/combo-therapies-for-comorbidities-may-affect-ipfs-progression-study-finds/ … the “study” is embedded in this article.
Charlene.
Log in to reply.